CheolWon Park is currently the Head of business development and portfolio of Alvogen APAC. He joined Alvogen Korea as the Director of R&D in December 2014. He is responsible for strategizing product portfolio which is the foundation of APAC business growth.
Before joining Alvogen, CheolWon was the director of R&D center of Dream Pharma, which was acquired by Alvogen. He has also held several business development, corporate strategy and R&D leadership roles in leading pharmaceutical companies in Korea, including CJ Cheiliedang (currently CJ Healthcare) and LG Life Science.
CheolWon Park graduated from Seoul National university with a Master degree in Pharmacy.